Article
Metabolomic characterization of human glioblastomas and patient plasma: a pilot study
2024-09-19
Abstract excerpt
<h4>Background: </h4> Glioblastoma (GBM) is a clinically challenging primary brain tumor with poor survival outcome despite surgical resection and intensive chemoradiation. The metabolic heterogeneity of GBM can become biomarkers for treatment response, resistance, and outcome prediction. The aim of the study is to investigate metabolic distinctions between primary and recurrent GBM tissue and patient plasma to es...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af387e56-1290-5186-b6e8-a5691cb6e9c3
- DOI
- 10.12688/f1000research.143642.5
